| Announce Date | 10/22/2025 |
| EPS Normalized Actual | $1.84 (Beat by $0.42) |
| EPS GAAP Actual | $1.84 (Beat by $0.42) |
| Revenue Actual | $0.1901B |
| Revenue Surprise | Beat by $190.1M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.14 |
| EPS GAAP Estimate | $1.14 |
| Revenue Estimate | $1.886993076B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 0 |
| Dec 2027 | 7.14 | 9.01 | 6.99745 | 7.2385 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.84 | 0.39333 | 0.1901B | -769.38% | -1598.21M |
| FQ2 2025 (Jun 2025) | 1.41 | -0.16333 | 0.1505B | -971.3% | -1693.53M |
| FQ1 2025 (Mar 2025) | 0.72 | -0.16667 | 1.5823B | 9.97% | 6.23M |
| FQ4 2024 (Dec 2024) | 0.7 | -0.448 | 1.6851B | 15.18% | 17.96M |
| FQ3 2024 (Sep 2024) | -1 | -1 | 1.6527B | 10.38% | 1652.7M |
| FQ3 2001 (Sep 2001) | 0 | 0 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | 1.11 | 1.11 | 1.6123B | -2.15% | 1612.3M |
| FQ1 2024 (Mar 2024) | 0.45 | 0.45 | 1.4246B | -1.51% | 1424.6M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.14
Consensus Revenue Estimates
1.886993076B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 1.86 | -- | 1.73419 | 1.91735 | 1 |
| FQ2 2027 (Jun 2027) | 1.84 | -- | 1.71554 | 1.89673 | 1 |
| FQ1 2027 (Mar 2027) | 1.23 | -- | 1.1468 | 1.26792 | 1 |
| FQ4 2026 (Dec 2026) | 1.39 | -- | 1.29367 | 1.53157 | 1 |
| FQ3 2026 (Sep 2026) | 1.91 | 3.66 | 1.77763 | 2.10454 | 1 |
| FQ2 2026 (Jun 2026) | 1.97 | 28.43 | 1.83347 | 2.17065 | 1 |
| FQ1 2026 (Mar 2026) | 1.14 | 36.84 | 1.06099 | 1.25611 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 2.2B | -- | 2.09B | 2.25B | 2 |
| FQ2 2027 (Jun 2027) | 2.14B | -- | 2.03B | 2.19B | 2 |
| FQ1 2027 (Mar 2027) | 1.85B | -- | 1.76B | 1.9B | 2 |
| FQ4 2026 (Dec 2026) | 2.03B | -- | 1.92B | 2.19B | 1 |
| FQ3 2026 (Sep 2026) | 2.16B | 91.21 | 2.05B | 2.33B | 1 |
| FQ2 2026 (Jun 2026) | 2.22B | 93.22 | 2.1B | 2.39B | 1 |
| FQ1 2026 (Mar 2026) | 1.89B | 16.15 | 1.79B | 2.03B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.44667 | 1.84 | 0.39333 | 21.38% |
| FQ2 2025 (Jun 2025) | 1.57333 | 1.41 | -0.16333 | -11.58% |
| FQ1 2025 (Mar 2025) | 0.88667 | 0.72 | -0.16667 | -23.15% |
| FQ4 2024 (Dec 2024) | 1.148 | 0.7 | -0.448 | -64% |
| FQ3 2024 (Sep 2024) | -1 | -1 | 100% | |
| FQ3 2001 (Sep 2001) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 1.11 | 1.11 | 100% | |
| FQ1 2024 (Mar 2024) | 0.45 | 0.45 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.79B | $0.19B | $-1598.21M | -840.72% |
| FQ2 2025 (Jun 2025) | $1.84B | $0.15B | $-1693.53M | -1125.27% |
| FQ1 2025 (Mar 2025) | $1.58B | $1.58B | $6.23M | 0.39% |
| FQ4 2024 (Dec 2024) | $1.67B | $1.69B | $17.96M | 1.07% |
| FQ3 2024 (Sep 2024) | $0B | $1.65B | $1652.7M | 100% |
| FQ3 2001 (Sep 2001) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $1.61B | $1612.3M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.42B | $1424.6M | 100% |